T1	chemical 43 53	fluoxetine
T2	disease_or_phenotypic_feature 79 92	renal failure
T3	disease_or_phenotypic_feature 110 132	Vascular insufficiency
T4	chemical 193 200	glucose
T5	chemical 208 214	oxygen
T6	chemical 385 392	antigen
T7	disease_or_phenotypic_feature 435 452	pancreatic cancer
T8	chemical 454 464	Bortezomib
T9	chemical 479 499	proteasome inhibitor
T10	chemical 539 543	drug
T11	chemical 574 584	bortezomib
T12	disease_or_phenotypic_feature 647 668	peripheral neuropathy
T13	disease_or_phenotypic_feature 791 812	peripheral neuropathy
T14	chemical 857 861	drug
T15	chemical 863 873	paclitaxel
T16	disease_or_phenotypic_feature 914 929	cardiac failure
T17	disease_or_phenotypic_feature 938 953	pulmonary edema
T18	chemical 990 1000	anesthesia
T19	disease_or_phenotypic_feature 1049 1058	psoriasis
T20	chemical 1090 1100	antagonist
T21	chemical 1101 1111	etanercept
T22	disease_or_phenotypic_feature 1130 1144	ovarian cancer
T23	chemical 1163 1171	antigens
T24	chemical 1209 1217	antigens
T25	disease_or_phenotypic_feature 1272 1282	infections
T26	chemical 1343 1349	oxygen
T27	disease_or_phenotypic_feature 1355 1381	retinopathy of prematurity
T28	disease_or_phenotypic_feature 1386 1395	blindness
T29	chemical 1404 1408	food
T30	disease_or_phenotypic_feature 1420 1427	obesity
T31	chemical 1447 1451	milk
T32	chemical 1452 1460	hormones
T33	disease_or_phenotypic_feature 1484 1491	obesity
T34	chemical 1513 1524	amphetamine
T35	disease_or_phenotypic_feature 1536 1543	obesity
T36	chemical 1550 1553	RAS
T37	disease_or_phenotypic_feature 1578 1584	cancer
T38	chemical 1585 1592	biology
T39	chemical 1702 1710	Mannitol
T40	chemical 1714 1718	drug
T41	disease_or_phenotypic_feature 1776 1789	renal failure
T42	chemical 1809 1817	antigens
T43	disease_or_phenotypic_feature 1851 1864	neuroblastoma
T44	chemical 1873 1881	antigens
T45	disease_or_phenotypic_feature 1918 1933	choriocarcinoma
T46	chemical 1935 1945	Fluoxetine
T47	chemical 1950 1959	serotonin
T48	disease_or_phenotypic_feature 1963 1969	autism
T49	chemical 2050 2054	drug
T50	disease_or_phenotypic_feature 2071 2074	CTX
T51	chemical 2084 2087	DDP
T52	chemical 2161 2170	inhibitor
T53	chemical 2180 2189	galactose
T54	disease_or_phenotypic_feature 2190 2198	cataract
T55	missed_disease_or_phenotypic_feature 57 66	depressed
R1	treats Arg1:T1 Arg2:T55	
T56	missed_disease_or_phenotypic_feature 628 642	hematotoxicity
T57	missed_disease_or_phenotypic_feature 604 619	adverse effects
R2	causes_or_contributes_to Arg1:T11 Arg2:T57	
R3	causes_or_contributes_to Arg1:T11 Arg2:T56	
R4	causes_or_contributes_to Arg1:T11 Arg2:T12	
R7	causes_or_contributes_to Arg1:T15 Arg2:T13	
R8	causes_or_contributes_to Arg1:T18 Arg2:T17	
R9	treats Arg1:T21 Arg2:T19	
T61	missed_disease_or_phenotypic_feature 1026 1044	bullous pemphigoid
T62	corrected_chemical 1068 1100	tumor necrosis factor antagonist
R10	treats Arg1:T62 Arg2:T19	
R11	treats Arg1:T21 Arg2:T61	
R12	treats Arg1:T62 Arg2:T61	
T63	corrected_chemical 1330 1349	supplemental oxygen
R13	causes_or_contributes_to Arg1:T63 Arg2:T27	
R14	causes_or_contributes_to Arg1:T63 Arg2:T28	
R15	treats Arg1:T34 Arg2:T35	
R16	causes_or_contributes_to Arg1:T39 Arg2:T41	
T64	missed_disease_or_phenotypic_feature 1734 1764	decrease intracranial pressure
R17	causes_or_contributes_to Arg1:T39 Arg2:T64	
T66	corrected_chemical 2144 2170	aldose reductase inhibitor
R18	treats Arg1:T66 Arg2:T54	
R19	causes_or_contributes_to Arg1:T53 Arg2:T54	
R5	causes_or_contributes_to Arg1:T14 Arg2:T13	
R6	causes_or_contributes_to Arg1:T40 Arg2:T64	
R20	causes_or_contributes_to Arg1:T40 Arg2:T41	
T58	missed_disease_or_phenotypic_feature 2065 2070	EMT-6
R21	treats Arg1:T49 Arg2:T58	
T59	missed_disease_or_phenotypic_feature 2078 2083	EMT-6
T60	missed_chemical 2071 2074	CTX
R22	treats Arg1:T60 Arg2:T58	
R23	treats Arg1:T51 Arg2:T59	
